Preventive Effects of Sustainable and Developmental Perioperative Oral Management Using the "Oral Triage" System on Postoperative Pneumonia after Cancer Surgery.

cancer surgery minimal human resources oral care oral triage perioperative oral management postoperative pneumonia

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
10 06 2021
Historique:
received: 02 05 2021
revised: 05 06 2021
accepted: 08 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

Perioperative oral management is widely recognized in the healthcare system of Japan. Conventionally, the surgeon refers patients with oral problems to a dental or oral surgery clinic in the hospital. However, frequent in-house referrals were found to increase the number of incoming patients resulting in unsustainable situations due to an insufficient workforce. In 2011, the Center for Perioperative Medicine was established at our hospital to function as a management gateway for patients scheduled to undergo surgery under general anesthesia. The "oral triage" system, wherein a dental hygienist conducts an oral screening to select patients who need preoperative oral hygiene and functional management, was established in 2012. A total of 37,557 patients who underwent surgery at our hospital from April 2010 to March 2019 (two years before and seven years after introducing the system) were evaluated in this study. The sustainability and effectiveness of introducing the system were examined in 7715 cancer surgery patients. An oral management intervention rate of 20% and a significant decrease in the incidence of postoperative pneumonia (aOR = 0.50,

Identifiants

pubmed: 34200726
pii: ijerph18126296
doi: 10.3390/ijerph18126296
pmc: PMC8296101
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Infect Dis. 2011 Nov;11(11):845-54
pubmed: 21798809
J Infect Chemother. 2020 Jan;26(1):58-62
pubmed: 31353202
Br J Surg. 2018 Nov;105(12):1688-1696
pubmed: 30088267
Circ J. 2016 Oct 25;80(11):2289-2290
pubmed: 27725418
Lancet. 1999 Aug 7;354(9177):515
pubmed: 10465203
Nihon Geka Gakkai Zasshi. 2017 Mar;118(2):155-60
pubmed: 30183176
Surgery. 2019 May;165(5):1003-1007
pubmed: 30765141
Medicine (Baltimore). 2017 Aug;96(33):e7436
pubmed: 28816937
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Clin Exp Dent Res. 2020 Apr;6(2):165-173
pubmed: 32250567
Surgery. 2010 Apr;147(4):497-502
pubmed: 20004439
J Am Geriatr Soc. 2008 Mar;56(3):577-9
pubmed: 18315680
Medicine (Baltimore). 2019 Apr;98(17):e15376
pubmed: 31027127
Anticancer Res. 2019 Jun;39(6):2711-2714
pubmed: 31177105
Clin Oral Investig. 2019 Sep;23(9):3581-3588
pubmed: 30623308
Support Care Cancer. 2011 Mar;19(3):409-16
pubmed: 20232086

Auteurs

Hideki Sekiya (H)

Department of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.

Yasuhiro Kurasawa (Y)

Department of Oral & Maxillofacial Surgery, Tokyo Medical & Dental University, Tokyo 113-0034, Japan.

Kosuke Kaneko (K)

Department of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.

Ken-Ichiro Takahashi (KI)

Department of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.

Yutaka Maruoka (Y)

Department of Oral & Maxillofacial Surgery, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.

Yukihiro Michiwaki (Y)

Department of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Department of Oral & Maxillofacial Surgery, Musashino Redcross Hospital, Tokyo 180-8610, Japan.

Yoshimasa Takeda (Y)

Department of Anesthesiology (Omori), School of Medicine, Toho University, Tokyo 143-8541, Japan.

Ryoichi Ochiai (R)

Department of Anesthesiology (Omori), School of Medicine, Toho University, Tokyo 143-8541, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH